Bolt Biotherapeutics (BOLT) Competitor Comparison
We are evaluating the key criteria listed to compare Bolt Biotherapeutics (BOLT) against its competitors in the Biotechnology industry.
Market Capitalization
299 / 368Gross Profits
119 / 278Total Revenue
192 / 300EBITDA
171 / 337Free Cashflow
204 / 352Quick Ratio
143 / 357Earnings per Share
186 / 359Dividend yield
0 / 5Total Cash
201 / 358Performance 3 years
339 / 368Performance 5 years
333 / 368Performance 10 years
304 / 368Linearity 3 years
318 / 368Linearity 5 years
314 / 368Linearity 10 years
301 / 368Total Rank
280 / 368Dividend Rank
71 / 368Valuation Rank
19 / 368Piotroski Rank
214 / 368Muliplier Rank
24 / 368Performance 3 years - BOLT ranking 339 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.